Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed software/version identifier was incremented from “v3.5.2” to “v3.5.3,” indicating a minor site update without altering the trial record information.
    Difference
    0.2%
    Check dated 2026-04-24T05:50:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page history shows a new site revision (v3.5.2) replacing the previous revision (v3.5.0).
    Difference
    0.1%
    Check dated 2026-04-17T02:33:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0; no changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:21.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:03.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the v3.4.1 notice about government funding was removed; these are administrative updates that do not affect core study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T11:47:50.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding affecting updates and changed the page revision to v3.4.1; the previous v3.4.0 entry was removed.
    Difference
    0.6%
    Check dated 2026-02-04T10:27:40.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.